Tropical Medicine Department, Tanta University, Tanta, Egypt.
Pathology Department, Tanta University, Tanta, Egypt.
Antiinflamm Antiallergy Agents Med Chem. 2020;19(3):302-312. doi: 10.2174/1871523018666190625164100.
Effective screening of colorectal cancer (CRC) in early stage could reduce the advancement of CRC and therefore mortality. Effective screening is based on either stool dependent tests or colon dependent examination.
The aim of the study was a comparative evaluation of chromocolonoscopy and Colon Cancer-Specific Antigen-2 test for early detection of colorectal cancer in Egyptian patients.
This case control study was carried out on 55 patients classified into 3 groups: Group I consisted of twenty patients with precancerous lesions detected by colonoscopy, Group II consisted of twenty patients diagnosed with colorectal cancer and Group III consisted of fifteen individuals (who underwent colonoscopy for other indications) as a control group. All the subjects were subjected to measure occult blood in the stool, measurement of Colon Cancer-Specific Antigen-2 level in serum and tissue and chromo colonoscopy using Indigo Carmine stain.
In group II, there was a statistically significant increase in CCSA2 in serum as compared to the other 2 groups. Cutoff >11.3 CCSA2 in serum showed 65% sensitivity, 85% specificity, 81.2% PPV, 70.8% NPV and 70.3% accuracy in the differentiation of group II with cancer colon from group I with premalignant colonic lesions. A cutoff > 9.1 CCSA2 in serum showed 95% sensitivity, 46.67% specificity, 70.4% PPV, 87.5% NPV and 73.5% accuracy in differentiating group II with cancer colon from normal controls (group III).
CCSA-2 level in serum was significantly higher in cancer colon. Chromoendoscopy has a role in the detection of polyps, both neoplastic and non-neoplastic.
有效的结直肠癌(CRC)早期筛查可以降低 CRC 的进展,从而降低死亡率。有效的筛查是基于粪便依赖的测试或结肠依赖的检查。
本研究旨在比较chromocolonoscopy 和 Colon Cancer-Specific Antigen-2 试验在埃及患者结直肠癌早期检测中的应用。
这项病例对照研究共纳入 55 例患者,分为 3 组:第 I 组有 20 例患者通过结肠镜检查发现癌前病变,第 II 组有 20 例患者诊断为结直肠癌,第 III 组有 15 例患者(因其他原因接受结肠镜检查)作为对照组。所有患者均进行粪便潜血检测、血清和组织 Colon Cancer-Specific Antigen-2 水平检测和 chromo 结肠镜检查,采用靛胭脂染色。
在第 II 组中,血清中的 CCSA2 水平与其他两组相比有统计学意义的升高。血清中 CCSA2 > 11.3 的截断值在区分有癌性结肠的第 II 组与有癌前结肠病变的第 I 组时具有 65%的敏感性、85%的特异性、81.2%的阳性预测值、70.8%的阴性预测值和 70.3%的准确性。血清中 CCSA2 > 9.1 的截断值在区分有癌性结肠的第 II 组与正常对照组(第 III 组)时具有 95%的敏感性、46.67%的特异性、70.4%的阳性预测值、87.5%的阴性预测值和 73.5%的准确性。
血清中 CCSA-2 水平在癌性结肠中显著升高。chromoendoscopy 在检测息肉方面具有作用,包括肿瘤性和非肿瘤性息肉。